Bio Green Med Solution, Inc. — Director's Dealing 2019

Dec 10, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cyclacel Pharmaceuticals, Inc. (CYCC)
CIK: 0001130166
Period of Report: 2019-12-05

Reporting Person: McBarron Paul (Director, E. VP, Fin, CFO and COO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-12-05	Option	$1.74	A	13022	Acquired	2027-12-29	Common Stock (13022)	Direct
2019-12-05	Option	$1.56	A	11980	Acquired	2028-02-22	Common Stock (11980)	Direct

Footnotes

F1: On December 29, 2017, Paul McBarron was granted an option to purchase certain shares of common stock, which option shall vest according to the satisfaction of performance criteria. Certain performance criteria were confirmed to have been met on December 5, 2019, resulting in the vesting of the option as to 13,022 shares.

F2: On February 22, 2018, Paul McBarron was granted an option to purchase certain shares of common stock, which option shall vest according to the satisfaction of performance criteria. Certain performance criteria were confirmed to have been met on December 5, 2019, resulting in the vesting of the option as to 11,980 shares.